Cardio Diagnostics announced that India’s Patent Office has granted a patent to the University of Iowa Research Foundation, or UIRF, under patent number 484488, titled “A Kit for Determining Methylation Status of a CpG Dinucleotide and a Genotype of a Single Nucleotide Polymorphism.” The patent was exclusively licensed to the Company from the University of Iowa Research Foundation, or UIRF. It was co-invented by Cardio Diagnostics’ founders, Meesha Dogan and Robert Philibert, the CEO and chief medical officer of the Company, respectively.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CDIO: